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Among  the  extracellular  growth  products  of  hemolytic  streptococci  is  a 
recently  discovered protein  that  inhibits  the  oxidation  of citrate,  fumarate, 
and alpha-keto-glutarate by mitochondria  (1). This protein has been purified 
and has been shown to catalyze specifically the cleavage of diphosphopyridine 
nucleotide  (DPN) at the nicotinamide-ribose linkage (2). 
It  was  not  known  whether  the  release  of  diphosphopyridine  nucleotidase 
(DPNase) accompanies growth of bacteria in general or whether it is uniquely 
associated with streptococci or with particular strains of streptococci. In order 
to  answer  this  question  we  have examined for DPNase  activity the  culture 
supernates of diverse bacterial species and of a  series of streptococcal strains. 
The findings suggest that DPNase is not commonly encountered as an extra- 
cellular  growth  product  of  bacteria  excepting  certain  kinds  of  streptococci. 
Special attention has been given to streptococci in order to see whether capacity 
of these  organisms to  release  DPNase  is associated  with  other  properties as 
serological type, pathogenicity, and leukotoxicity. 
Materials and Metkods 
Bacterial Strains.--Strains representative of bacterial species other than streptococci were 
obtained from the stock culture collection maintained in the New York laboratory for teach- 
ing purposes. A large number of streptococcal cultures of various groups and types were avail- 
able in the two laboratories, and many of these had been obtained initially from Dr. Rebecca 
C. Lancefield. A considerable number of strains of streptococci known to have been associated 
with nephritis were obtained from Dr. Charles H. Rammelkamp, Jr., Dr. Floyd W. Denny, 
Jr., and Dr. Lewis W. Wannamaker. Several strains of streptococci isolated from rheumatic 
fever patients were supplied by Dr. Angelo Taranta, a series of cultures of pneumococci by 
Dr. Robert Austrian and Dr. Harriet Bernheimer, and a number of strains of Clostridium 
perfringens by Dr. L. S. McClung. The authors record with pleasure their gratitude to these 
persons. 
*  This  study  was  supported  in  part  by  grants  from  the  Life  Insurance  Medical  Research 
Fund, the Masonic Foundation for Medical Research and Human Welfare, and the Helen 
Hay Whitney Foundation. 
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Culture Methods Used in Routine Survey.--The  following media were employed in volumes 
of 10, 25, and 50 ml.: (a~ For all species other than streptococci, pneumococci, and clostfidia, 
neopeptone infusion broth (4); (b) for clostridia, neopeptone infusion broth containing 0.01 
per cent sodium thioglycolate; (c) for streptococci and pneumococci, the same as (b) with and 
without 1 per cent horse serum~ The media were seeded either directly from lyophili~.ed  cul- 
tures or from growth on streak-plates without any attempt  to  standardize the  inoculum. 
Cultures were incubated at 37  ° and checked  for purity by microscope examination and by 
plating. Two aliquots, usually 2 ml. each, were taken after 24 hours~  incubation, one for esti- 
mation of growth and one for estimation of extracellular DPNase. In many instances, aliquots 
were taken also after 48 hours of incubation, but  because growth was usually maximal in 24 
hours and because DPNase was not found to be increased by the longer period of incubation, 
only the 24 hour measurements are given. 
F_.stimation of C-rowth.--As an index of bacterial growth, the optical density of one of  the 
culture samples was read in a  Beckman model  DU spectrophotometer,  at 650  m/z,  against 
a  sterile broth blank. 
JF~sHmaHan of DPNase.--The other culture sample was spun at high speed in a Sorvall SS-1 
centrifuge for 10 minutes. DPNase activity of the clear supernatant fluid was measured by 
a modification (2) of the method of Kaplan, Colowick, and Nason (3) which involves measure- 
ment of the absorption of the complex formed between cyanide and DPN before and after 
incubation with enzyme.  Dilutions of culture supernate were prepared in 0.1  ~  potassium 
phosphate buffer, pH 7.3, containing 0.1 per cent bovine serum albumin. The reaction mixture 
contained 0.1 mi. of appropriate dilution of culture superuate and 0.4 ml. of DPN (i rag. per 
mi.). The DPN was obtained from Sigma Chemical Company and was stated to be 90 to 95 
per cent pure. After mixing, the solution was placed in a water bath at 37  ° for 7.5 minutes. 
At the end of this time 3 ml. of 1.0 ~r NaCN were added, and the optical density read at  340 
m/~. The unit of DPNase activity is that amount which causes a splitting of 0.01 #~ of DPN 
under  the  conditions  stated.  Estimations  of  activity were  based  on  dilutions  of  culture 
supernates causing splitting of not more than 60 per cent of the coenzyme. 
EXPERIMENTAL 
Course  of  Appearance  o/  Extracellular  DPNase.--In  order  to  follow  the 
appearance of extracellular DPNase during growth of the streptococci,  several 
experiments were carried out in which cultures were sampled hourly for estima- 
tion of activity and of growth. The results of one such experiment, employing a 
Group A streptococcus,  type 6, Strain $43/75, are given in Fig. 1. At time zero, 
10 ml. of a broth culture of this strain were added to 90 ml. of broth containing 
1 per cent horse serum and 0.01 per cent thioglycolate.  It can be seen that the 
secretion of enzyme followed closely the course of growth.  During the time in 
which much  of  the  growth  occurred,  appearance  of  enzyme  lagged  behind 
synthesis of bacterial protoplasm by a time interval of approximately  1.5 hours. 
The lag can represent either a delay in enzyme synthesis  or a delay in release 
of preformed enzyme. 
Failure  of Microorganisms Other Than Particular  Varieties  o/Streptococci  to 
Release DPNase.--Culture  supernates  of the following  45  species  of bacteria 
and yeasts were  assayed  for DPNase.  Strain  designations,  when known, are 
given in parentheses:-- A. W. BERN]IEI~R, P. D. LAZARIDES, AND A. T. WILSON  29 
Actinomyces boris (3007), Mycobactorium phlei (10142), M. smegmatis (NN'S 101), Coryne- 
bacterium dlphtherlae gravis  (Mueiler), C. dipktkeriae intermedius (Mueller), C. dip~keriae 
(NYS P8), C. xerosis (NYS 155), C. xerosis, C. pyogenes, Vibrio metckniko~ii (ATCC 6362), 
Neisseriu  catarrha/is (Comeil), Leu~onostoc mesenterioides (BS237 (B512) (B742), Gaffkya 
~ragena, Diplococcus pneumoniae (SVI) (A66) (A66 R27 (D39S) (NYU IV) (NYU V) (VI H) 
(VII F) (VIII B), Streptococcus viridaus (16ST) (N-BSI7 (Els),  Streptococcus sa/ivarius (520B), 
Micrococcus aureus (C2083) (JH16)  (35) (37), M.  citreus (95107, M.  a/bus (3895), M. 
lysodeikticus, Flavobacteriura.f~avescens  (8315), Proteus va/garis, P. ~a/garis (No. 16), P. morganii 
(299), Esckerichia coli (F15) (ML 308) (07, Aerobacter aerogenes (ES 173-0), Klebsiella pneu- 
monlae (Type A McKibben),  Alcaligenes  faua/is (ESST), Salmonella typki (57), S. paratypki 
B (Java), Shigella skigae (D6), Lactobacillus cacei, Pasteurdla a~icida (Hopkln~) (NY i01) 
(NY 81) (fowl  cholera), P. lepisept~a (0) (D195) (NYS 328067, Haemophilus influennae type 
0.230 
=-- 0.200 
'==  0:15C 
o 
o 
==  0.100 
~  0.050 
.= 
M.I 
0 
1120 
,  ! 
2 
L GROWTH 
l  oEXTRACELLULAR  DPNASE 
16HOURS 
f  t  ,  I..v~vv~.!  I  ,  !  ,  I  , 
4  6  8  24  26  28  30 
HOURS 
960 
800 
640  =__ 
480 
3:~0 _, 
160 
0 
32 
FIo, 1. Course of growth and appearance of extracellular  DPNase. 
B, Bacillus subt~us, B. cereus, B. megatherium (KM), B. paiustris, Clostridium perfringens 
(NYS) (814) (671) (146) (150), Cl. perfringens A (841), Cl. perfringens B (803), Cl. perfringens 
C (804), CL perfringens D (805), CL perfiingens F (1228), Cl. sept~ura (54) (44 708) (VS32) 
(Robertson IID (59) (BX96), Cl. tetani (F3 Squibb) (Wilcox),  CL bo~ulinum (type B Nevins), 
Cl. kistolyticum, Cl. sporogenes, Cl. tetanomorphum, Candida a/blcans, C. stdlatoidea (110067, 
Saccharomyces cerevisiae. 
In no instance was there any indication of presence of DPNase. The lowest 
concentration of enzyme that can be measured by the method of assay used 
is approximately 50 units per ml. Hence if DP2ffase were present in amounts 
substantially less than this, it would not have been detected. In view of the 
variety of extraceUular enzymes and toxins known to be formed by clostridia it 
is notable that none of the 22 strains examined yielded DPN'ase. 
Capacity  of Streptococci  Bdonging  to  Lancefield  Groups  A  to  M  to  Rdease 
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selected with any particular property in mind, but were tested in order to gain 
some idea of the frequency with which  DPNase-producing streptococci  are 
encountered.  Fifty-eight of these strains belonged to Group A, 5 to Group B, 
8 to Group C, 9 to Group D, 3 to Group G, and 11 to Groups E, F, H, L, and 
M. The types of results obtained are illustrated in Table I  which shows the 
growth attained, and the DPNase activity found, in the culture supernates of a 
few strains.  Thirty-seven strains were found capable of producing  the enzyme 
while 57 strains failed to form detectable DPNase. Of the 37, 32 belonged to 
Group A, 4 to Group C, and I to Group G. The frequency of DPNase-producing 
strains among the Group A streptococci of this series was 32/58 or 55 per cent. 
TABLE I 
Growth and Extracdlular DPNase of Six Strains of Group A  Streptococci 
Strain  Group 
B607  A 
1685  A 
366  A 
Tll  A 
Wilson 868  A 
C775  A 
Type 
1 
3 
4 
11 
12 
36 
Broth 
Growth  DPNsse 
opt@al density  uni~/ml. 
units 
0.130  ND* 
0.175  325 
0.345  950 
o. 18o  TR?~ 
o. 145  60 
0.160  ND 
Broth contsinlng 
I per cent serum 
Growth  DPNsse 
opt~  denslty  I 
un~s 
0.195 
0.165 
0.325 
0.100 
0.300 
0.260 
units]ral. 
ND 
665 
1330 
220 
440 
ND 
* ND indicates that no DPNase activity was detected. 
:~ TR? indicates less than 50 units of DPNase per ml. 
Capacity of Streptococci Associated with Rheumatic Fever to Release DPNase.-- 
Seventeen of the Group A streptococcal strains of the foregoing series had been 
isolated from children  in whom an attack of rheumatic fever subsequently 
occurred.  Strains of types 2, 5, 6, 12, 13, 18, 19, 30, and 32 were represented. 
Nine, or 53 per cent, of these strains were found to produce DPNase. 
Capacity of "Nephritogenic" Streptococci  to Release  DPNase.--A preliminary 
survey  of  DPNase-production  relative  to  serological  type  suggested  that 
proliferation of group A streptococci belonging to types 12 and 4, among others, 
is frequently accompanied  by release of DPNase. Because  poststreptococcal 
nephritis, when it occurs, not infrequently follows infections with streptococci 
of these types (5) a series of 41  Group A strains that had been isolated from 
patients having nephritis, and that are believed  to have been the etiologic 
agents in these cases, were tested. The cultures were originally isolated in a 
variety of places  at various times.  The results (Table II)  show that in the 
presence of 1 per cent serum, growth of 39 of the 41 strains was accompanied 
by release of enzyme. A.  W.  BERNKEr~F.R~  p.  D.  LAZARIDES~  AND  A.  T.  WILSON  31 
TABLE  II 
Growth  and  Extracdlular  DPNase  of Streptococci  Associated  with  Acute  Nephritis 
K.M. 
T.L. 
E.K. 
M.K. 
GT-482 P. 
D.DeM. 
A. 
R.L. 
C.B. 
L.S. 
E.J. 
B, 
D.H. 
B-25 
N. 
O. 
F. 
Str~ia  Type 
4 
4 
4 
4 
4 
12 
12 
12 
12 
12 
12 
12 
12 
12 
12 
12 
12 
Cleveland, 
Hawaii, 
lC 
Nashville, 
Cleveland, 
~c 
~c 
cC 
Wyoming, 
Bainbridge, 
gc 
Source 
1952  (R)* 
1953  (R) 
1953  (R) 
"  (R) 
1954  (D) 
1950  (R) 
1951  (R) 
1952  (R) 
1953  (R) 
1954  (R) 
"  (R) 
"  (R) 
1953  (R) 
1952  (R) 
"  (R) 
"  (R) 
"  (R) 
A002 (33a) 
A090 (25a) 
W. 
V. 
N. 2044 
GT-1 
GT-123 
GT-207 
GT-225 
GT-36O 
GT-374 
GT-464 
GT-465 
GT-536 
J. (1) 
s. (2) 
S.  (6) 
GT-86 S. 
GT-576 D. 
701 pp 
Hawaii 1 
Hawaii 2 
M.P. 
A.S. 
12 
12 
12 
12 
12 
12 
12 
12 
12 
12 
12 
12 
12 
12 
Red Lake 
tt  ~c 
?:~ 
? 
? 
? 
? 
? 
? 
New York, 
Philadelphia, 
Nashville, 
cc 
lc 
lc 
,c  lc 
Chile,  1956 
Minnesota,  1953 
Nashville,  1953 
"  1955 
Chicago,  1951 
Hawaii,  1951 
Cleveland,  1951 
Florida,  1957 
"  (R) 
"  (R) 
"  (R) 
1953  CL) 
1948  (L) 
1953  (D) 
"  (D) 
1954  (D) 
"  (D) 
(D) 
(D) 
(O) 
(D) 
(D) 
(W) 
(W) 
(W) 
(D) 
(D) 
(R) 
(R) 
(R) 
(R) 
(R) 
DPNase in 1 
per cent 
serum broth 
un/~/mL 
1085 
735 
74 
81 
685 
315 
86O 
1055 
945 
945 
985 
1500 
810 
1510 
945 
685 
1100 
1155 
1085 
1015 
265 
135 
1050 
1085 
1085 
1085 
875 
1155 
1400 
1015 
1085 
440 
485 
485 
345 
310 
345 
ND 
ND 
205 
335 
* (R), Dr. Charles H. Rammelkamp,  Jr.;  (D), Dr.  Floyd W. Denny, Jr.;  (L), Dr. 
C.  Lancefield;  (W),  Dr.  Lewis  W.  Wannamaker. 
~: "?"  indicates not typeable or  type in doubt. 
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TABLE IH 
ExtraceUular DPNase and  'IJeukotoxicit~ 
Strain 
327W 
Type 1 
Type 1/119/15 
Type 2/44/16 
Group 
A 
A 
A 
A 
AD238B 
D58/49/7 
C2035 
95/R65 
366 M. 
E.K. 
M.K. 
K.M. 
T.L. 
1"6/]3409 
S43/TS 
B. 
GT-36O 
GT-374 
B-25 
[,B. 
L.S. 
F. 
!k002 (33a) 
R.L. 
~.090 (25a) 
W. 
E.J. 
~.. 
D.H. 
N. 
~.D242/27/2 
$26 W. 
Kawaii 1 
~d.P. 
~350 
220 
5133 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
C 
C 
G 
Type 
1 
1 
1 
2 
3 
3 
3 
4 
4 
4 
4 
4 
4 
6 
6 
11 
12 
12 
12 
12 
12 
12 
12 
12 
12 
12 
12 
12 
12 
12 
12 
12 
14 
36 
? 
? 
DPNase i~ broth 
unitslml. 
ND 
ND 
ND 
ND 
282 
45O 
815 
670 
95O 
ND 
ND 
425 
120 
810 
43O 
TR? 
410 
200 
510 
295 
245 
215 
205 
145 
26O 
275 
230 
ND 
135 
112 
92 
155 
ND 
ND 
ND 
120 
ND 
74 
ND 
DPNase in I  Leuko- 
per cent serum,  broth  toxicity 
smlts/ml. 
ND 
ND 
ND 
ND 
1120  + 
1850  + 
790  q- 
1260  + 
1330  + 
74  + 
81  + 
1085  + 
735 
1085  + 
1000  + 
110 
875  + 
1155  + 
1510  -k- 
1500  + 
945  + 
1100  + 
1155  + 
1055  + 
1085  + 
1015  + 
985  + 
ND 
860  + 
810  + 
945  + 
685  + 
ND 
ND 
ND 
205  + 
110  + 
320  + 
168  + 
Capacity of Leukotoxic Streptococci to Release DPNase.--Depending  upon the 
events which ensue after their ingestion by peripheral blood neutrophilic cells, 
streptococci can be classified into two groups, leukotoxic strains which kill the 
phagocytes and non-leukotoxic  strains which do not (6).  The type distribution A.  W.  BERNHEIMER,  P.  D.  LAZARIDES,  AND  A.  T.  WILSON  33 
of leukotoxicity and that of DPNase-forming ability suggested that the two 
phenomena may be related. 
A number of strains that had previously been tested for capacity to release 
DPNase  were  tested for leukotoxicity by a  method described elsewhere  (6) 
and other strains whose leukotoxic status had been established were tested for 
capacity to release DPNase in broth and in 1 per cent serum broth. The two 
types of information were obtained for a  total of 39 strains (Table III). The 
results show that 29  strains were leukotoxic, and that all of them produced 
DPNase. Ten strains were found to be non-leukotoxic, and 8 of these failed to 
form enzyme in detectable amount. The two strains that released DPNase but 
were non-leukotoxic constituted exceptions to an otherwise uniform association 
between leukotoxicity and DPNase production. 
The  concept  suggested  by this  correlation was  that  the  leukotoxicity of 
certain streptococci might be due to their capacity to form DPNase, and that 
DPNase therefore would be a leukotoxic agent. It had been shown earlier (6) 
that culture filtrates of leukotoxic cocci did not injure leukocytes when added 
to blood and observed microscopically. A purified and concentrated preparation 
of DPNase,  assayed at 34,000  units per ml. was added to blood and it also 
failed to produce visible injury to the white cells. This was thought not to rule 
out  the  possibility that  DPNase  was  leukotoxic,  for  its  failure to  produce 
leukocyte injury could result from inability to penetrate the cell membrane of 
the  leukocyte. A  mixture was made of the  DPNase  solution, blood,  and a 
suspension of non-leukotoxic streptococcus  (T2/44),  the idea being that the 
enzyme might be carried into the cell in the process of phagocytosis. But, al- 
though phagocytosis occurred rapidly and extensively, the blood cells were not 
visibly injured. This experiment, like the previous one, does not rule out the 
possibility that DPNase may be responsible for leukotoxicity,  for it is not known 
whether the enzyme was actually carried into the leukocytes. 
DISCUSSION 
The environmental factors that may affect the amount of DPNase activity 
found in the nutrient medium in which streptococci have grown have not been 
systematically studied. There are, however, a few observations, not evident in 
the preceding experimental section, that bear on this question. The enzyme 
does not appear to be an inducible one because it is formed in a  medium of 
essentially defined composition (7) presumably completely free from substrate. 
Moreover the addition to broth of DPN in concentrations ranging from 1 to 
1000 ~g. per ml. does not significantly alter the amount of enzyme found in 
culture supernates of enzyme-producing strains, nor does it induce DPN'ase- 
negative strains  to  elaborate  enzyme. On  the  other hand,  there  apparently 
exist in neopeptone infusion broth unidentified substances which do affect the 
amount of enzyme activity found in culture supernates; a single strain, C203S, 
has been observed to yield anywhere from 380 to 815 units of DPN-splitting 34  STILEPTOCOCCAL  DIPHOSPHOPYI~IDIN~  NUCLEOTIDASE 
activity when cultivated in different lots of broth, but without showing compa- 
rable differences in amounts of growth. 
Addition of 1 per cent horse serum to nutrient  broth was accompanied by 
increased DPNase in cultures of many strains of Group A  streptococci.  The 
magnitude of the serum effect varied considerably among different strains, and 
it is notable that several which showed scarcely detectable DPNase when grown 
in the absence of serum exhibited a substantial amount of enzyme activity when 
cultivated in the presence of serum. The serum effect has not been investigated 
further. 
One purpose of this study was to determine how commonly DPNase occurs 
as an extracellular product of bacterial growth. It is of interest that the enzyme 
was not encountered among cultures of bacterial species other than streptococci. 
Obviously, a  more exhaustive survey than  the present one might reveal the 
existence of other DPNase-producing species. Work in other laboratories has 
shown that Neurospora DPNase is found in  the  medium in  which  the mold 
grows as well as in extracts of the mycelial mat (3); that the endotoxin of the 
plague bacillus  (8)  appears to  be,  or  to have associated  with  it,  a  DPNase 
which, unlike the streptococcal enzyme, tends to be retained within the cell; 
and that intracellular DPNases are also present in certain other bacteria (9, 10). 
The  group  A  streptococci  examined  (Table  IV)  consisted  of  organisms 
belonging  to  21  different  M  protein  types.  Among  the  DPNase-producing 
strains of Group A, types 2, 3, 4, 5, 6, 11,  12, 13, 22,  25, 28, and Red Lake are 
represented, indicating that capacity to form the enzyme is not restricted to a 
small number of types. 
Among all group A streptococci studied (Table IV) 6 types were represented 
by more than  three  strains.  All  strains  of types  1  and  36  failed to produce 
DPNase. All strains of Type 3  produced the enzyme as did 52 of 56 type 12 
strains. 1 Most, but not all, strains of types 4 and 11 produced the enzyme. Thus 
there appears to be a tendency for DPNase to be produced by strains of certain 
types and not to be produced by strains of other types. This interpretation is 
weakened,  however, by the facts that  3  of the 8  type 1 strains were derived 
i The 4 strains that failed to produce DPNase were NY5,8115,  11275, and CN20. The 
first is a familiar stock strain that has been in artificial cultivation for several decades and 
which no longer produces detectable type 12 M protein. It is a strain that was originally  classi- 
fied as type 10 by agglutination reactions on the basis of its T antigen, but is now, in common 
with other strains of the same antigenic composition, classified as type 12 (11). Several other 
lines of NY5 that had reacquired the type 12 M protein  through  animal passage likewise 
failed  to  produce DPNase.  Strains  8115 and  11275 were isolated in  Rumania  by  Dr. 
F. Schwenkter and strain CN20 in England (?) by Dr. Edgar Todd. Interestingly, these three 
strains~ obtained from Dr. Lancefield, were found by her to possess, like NYS, the type 10 T 
antigen. Unfortunately agglutinating sera for identifying type 10 and  type 12  T  antigens 
were not available for testing the other type 12 strains studied here, and we cannot be certain 
that the 10 T variety may not be among them. A.  W.  BERANHEr~rRR, P.  D.  LAZARIDES, AND A.  T.  WILSON  35 
from the same patient, 2 of the 6 type 36 strains were isolated from one patient, 
and 2 other type 36 strains originated from one epidemic. The large number of 
type 12 strains studied furnishes convincing evidence that, except for the type 
10-T organisms, strains of type 12 failing to produce DPNase are not commonly 
DPNase-Forming Capacity of AU Stre. 
Group 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
B 
C 
D 
E 
F 
G 
H 
L 
M 
Type 
TABLE IV 
~tococcaI Strains Examined According to Group and Type 
Number of strains 
Tested  DPNase-podtive 
1  8 
2  2 
3  5 
4  14 
5  3 
6  3 
11  4 
12  56 
13  1 
14  1 
18  3 
19  3 
22  1 
25  1 
28  1 
30  2 
32  1 
36  6 
43  1 
48?  1 
Red Lake  3 
?  9 
5 
8 
9 
2 
2 
3 
2 
2 
3 
0 
1 
5 
13 
1 
3 
3 
52 
1 
0 
0 
0 
1 
1 
1 
0 
0 
0 
0 
1 
3 
7 
0 
4 
0 
0 
0 
1 
0 
0 
0 
DPNue-acgatlve 
encountered.  For other types, the numbers of strains studied are too small to 
permit definite conclusions to be drawn. 
Table II shows that 39 of 41 strains associated with acute glomerulonephritis 
were found capable  of producing DPNase.  In addition  to the  strains  listed, 
cultures derived from three other primary isolations from one of the patients 36  STREPTOCOCCAL  DIPHOSPHOPYRIDINE  NUCLEOTIDASE 
(Jiminez)  formed amounts of enzyme comparable  with those shown  in the 
table.  Cultures  were  obtained  from  two  relatives  of  the  nephritis  patient 
"Scheuring." These relatives did not develop nephritis,  but the type 12 strains 
isolated from them formed enzyme. There exist many other strains, moreover, 
which form DPNase but whose histories  contain no indication that infection 
was accompanied  by nephritis.  Nevertheless,  the high frequency with Which 
nephritogenic  strains produced DPNase, as compared with that (55 per cent) 
with which group A strains not selected for this property produced the enzyme, 
is notable. The data of Table IV indicate that DPNase may be formed with 
some degree of regularity by strains of a number of different antigenic types 
including types 12 and 4. Since a large proportion of the nephritogenic  strains 
tested belong to these two types, the observation that most of the nephritogenic 
strains are capable of releasing enzyme may not have special significance. On 
the other hand, the possibility that DPNase is involved in the pathogenesis of 
acute glomerulonephritis  merits further exploration. 
In an earlier report one of us (6) has discussed the capacity of certain strepto- 
cocci to injure leukocytes that have phagocytized them. The mechanism  by 
which the streptococci  injure leukocytes is unknown, but the possibility  can 
be put forward,  among others,  that the effect depends  upon elaboration of a 
specific toxic  substance.  The hypothetical leukotoxin  does not appear to be 
identifiable  with  any  of  the  previously studied streptococcal  products,  as 
erythrogenic toxin,  the streptolysins,  streptokinase, leukocidin,  etc.  (6). The 
remarkable  qualitative correlation  between  DPNase  production and leuko- 
toxicity, presented in Table III, suggests that the two functions are associated 
and may, perhaps,  be identical.  If they are identical,  the discrepancy of the 
two strains which produced the enzyme but appeared to have no leukotoxicity, 
must be explained. The most obvious explanation is that the measurement of 
leukotoxicity is a much less sensitive procedure than is assay for DPNase pro- 
duction and that the two strains would be shown to be lenkotoxic if the method 
could be improved. Another explanation is that the leukotoxic injury may de- 
pend on two microbial functions, of which one is DPNase production, and the 
other, unknown in character, is performed by all but the 2 discrepant strains. 
The failure of a purified, highly active DPNase preparation added to blood 
to injure leukocytes is in keeping with the observation that culture filtrates of 
leukotoxic cocci are not injurious.  If DPNase is leukotoxic, it must be so only 
when released from cocci within the cells. Attempts to adsorb the enzyme on 
inert phagocytizable particles have not yet been successful. 
The notion that leukotoxicity depends  upon DPNase production rests,  at 
present, on purely correlative  evidence, and a more direct demonstration of a 
causal relationship  is being sought. The tentative hypothesis may, however, be 
advanced  that  following  ingestion  of  a  leukotoxic  streptococcus,  DPNase 
passes  from the coccus into the substance of the phagocytic cell, and there 
produces a rapid destruction of DPN resulting in death of the phagocyte. A.  W.  BERN'HEIME.R,  P.  D.  LAZARIDES,  AND  A.  T.  WILSON  37 
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Among  170 streptococcal  strains,  there  were encountered 98 that yielded 
culture supernates which  caused splitting  of diphosphopyridine  nucleofide 
(DPN). All of the latter  belonged to Group A, C, or G. Release of DPNase 
accompanied the growth of diverse  antigenic  types of Group A  streptococci, 
and data on the frequency of DPNase-producing strains  for  certain  types are 
given.  In contrast,  cultures  representing  3 species  of yeasts  and 42 species  of 
bacteria  other  than  streptococci  of  the  Lancefield  groups  were  examined for  the 
presence  of  DPNase as  an  extracellular  product of  growth, but in  none of  these 
was the enzyme detected. 
Of the Group A streptococci examined, 41  strains had pedigrees suggesting 
that they were the etiologic agents of acute glomerulonephritis, and 39 of these 
were found to produce DPNase. 
There is an association between capacity of streptococi to form DPNase and 
capacity to kill leukocytes. A possible mechanism of leukotoxicity is suggested. 
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